[go: up one dir, main page]

IL149266A0 - Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension - Google Patents

Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension

Info

Publication number
IL149266A0
IL149266A0 IL14926600A IL14926600A IL149266A0 IL 149266 A0 IL149266 A0 IL 149266A0 IL 14926600 A IL14926600 A IL 14926600A IL 14926600 A IL14926600 A IL 14926600A IL 149266 A0 IL149266 A0 IL 149266A0
Authority
IL
Israel
Prior art keywords
dopamine
therapy
salt
receptor agonists
dependent hypertension
Prior art date
Application number
IL14926600A
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of IL149266A0 publication Critical patent/IL149266A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14926600A 1999-11-04 2000-10-31 Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension IL149266A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19953254 1999-11-04
PCT/EP2000/010770 WO2001032263A1 (en) 1999-11-04 2000-10-31 Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension

Publications (1)

Publication Number Publication Date
IL149266A0 true IL149266A0 (en) 2002-11-10

Family

ID=7928007

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14926600A IL149266A0 (en) 1999-11-04 2000-10-31 Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension

Country Status (15)

Country Link
EP (1) EP1233815A1 (en)
JP (1) JP2003513053A (en)
KR (1) KR20020062300A (en)
CN (1) CN1387450A (en)
AU (1) AU1390801A (en)
BR (1) BR0015310A (en)
CA (1) CA2389643A1 (en)
CZ (1) CZ20021521A3 (en)
HU (1) HUP0203024A2 (en)
IL (1) IL149266A0 (en)
MX (1) MXPA02004103A (en)
NO (1) NO20022142L (en)
RU (1) RU2002114818A (en)
WO (1) WO2001032263A1 (en)
ZA (1) ZA200204455B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180599A1 (en) * 2000-08-16 2002-02-20 Siemens Building Technologies AG Safeguarding device for a pump, which can be used in a fluid transmission
JP2010184889A (en) * 2009-02-12 2010-08-26 Nihon Univ Medicine for preventing and treating hypertension
BR112012008961A2 (en) * 2009-10-16 2019-09-24 Epiomed Therapeutics Inc emesis treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0817767B1 (en) * 1995-03-27 2000-05-24 Smithkline Beecham Plc Bicyclic amine derivatives and their use as anti-psychotic agents
FR2742149B1 (en) * 1995-12-11 1998-02-13 Inst Nat Sante Rech Med NOVEL 2-NAPHTAMIDE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS

Also Published As

Publication number Publication date
BR0015310A (en) 2002-07-09
HUP0203024A2 (en) 2003-02-28
JP2003513053A (en) 2003-04-08
NO20022142D0 (en) 2002-05-03
ZA200204455B (en) 2003-09-04
MXPA02004103A (en) 2003-08-20
CN1387450A (en) 2002-12-25
EP1233815A1 (en) 2002-08-28
AU1390801A (en) 2001-05-14
CA2389643A1 (en) 2001-05-10
RU2002114818A (en) 2004-01-10
WO2001032263A1 (en) 2001-05-10
NO20022142L (en) 2002-05-03
CZ20021521A3 (en) 2003-05-14
KR20020062300A (en) 2002-07-25

Similar Documents

Publication Publication Date Title
AU1293101A (en) Ep4 receptor selective agonists in the treatment of osteoporosis
PT1189916E (en) N-PYRAZOLE AGONISTS OF THE A2A RECEPTOR
IL147195A0 (en) C-pyrazole a2a receptor agonists
HU0200264D0 (en) Estrogen agonists/antagonists for the treatment of certain cancers
AU5274499A (en) Therapeutic chemokine receptor antagonists
HUP0203681A3 (en) Pharmaceutical compositions containing agonists specific for the peripheral cannabinoid receptor and their use
IL148719A0 (en) Kinase inhibitors as therapeutic agents
HUP0201184A3 (en) Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
HUP0202253A3 (en) Selective iglur5 receptor antagonists for the treatment of migraine
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
AU6228000A (en) The use of retinoid receptor antagonists in the treatment of prostate carcinoma
IL146151A0 (en) Human-g-protein receptor
IL145166A0 (en) Biphenyl derivatives as antagonists of the neurokinine-1 receptor
HUP0204448A3 (en) Trnasdermal therapeutic system for the delivery of lerisetron
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
GB9915995D0 (en) Non-steroidal sulphamate compounds for use as oestrone sulphatase inhibitors
AU4856600A (en) Use of agonists or antagonists of the 5-ht7 receptor to treat disorders of the bladder
AU5861900A (en) Receptor agonists and antagonists
IL149266A0 (en) Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension
AU6909400A (en) Partial agonists at the glycine modulatory site of the nmda receptor for treating cognitive dysfunction
ZA98484B (en) Use of beta3-adrenergic receptor agonists for the preparation of healing drugs
GB9927215D0 (en) Hormone receptor expression
AU2001250528A1 (en) Agonists/antagonists of the gpr56 receptor as appetite control agents
PL351127A1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
AU2002315522A1 (en) Receptor agonists useful for the treatment of pain